Topical Progesterone Cream Yields Prescription-Level Exposure - Study
This article was originally published in The Rose Sheet
Executive Summary
Topical progesterone cream results in the same level of exposure to progesterone as prescription oral micronized capsules, according to a small study presented by Anne Hermann, MD, at the annual meeting of the American Society for Clinical Pharmacology and Therapeutics in Miami March 25
You may also be interested in...
Hormone-Containing Cosmetics Rule Should Be Pursued – Advocacy Groups
Progesterone-containing topical cosmetics should be permitted on the market and FDA should pursue a final rule establishing such a policy, according to several alternative medicine and women's health advocacy groups
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle